EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial

Olynka Vega-Vega, Adrián E Caballero-Islas, Noemí Del Toro-Cisneros, Sergio Óscar Hernandez-Ordoñez, Mauricio Arvizu-Hernández, Armando Martínez-Rueda, Diana Camacho-Colin, Leidi Laura Gómez-Correa, Ricardo Correa-Rotter

Blood Purification · 2023 · 52 (7-8) · 712-720

DOI: 10.1159/000531355 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Blood Purification, online erschienen am 20.07.2023. Verfasst von Olynka Vega-Vega und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Hauptthemen laut MEDLINE: Hemodiafiltration, Kidney Failure, Chronic. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Expanded hemodialysis (HDx) is expected to provide enhanced permeability of medium-sized molecules, selective solute retention, and better internal retrofiltration. The primary objective of this study was to compare the efficiency for removal of β2-microglobulin with 3 different extracorporeal therapies (ETs): high-flux hemodialysis (HF), online hemodiafiltration (OL-HDF), and HDx. The secondary objective was to evaluate the efficiency of removal of other uremic toxins, including urea, phosphate, CRP, IL-6, IL-10, TNF-⍺, indoxyl sulfate, and p-cresol.

Methods

This single-center, randomized, and cross-over study was performed. Patients were randomized to determine the initial modality of treatment, each period lasted 4 weeks and between one modality and another, there was a washout period of 1 week. Reduction ratios (RRs) of different-size molecules and albumin were calculated for the different ET.

Results

Twenty-two patients were included, β2-microglobulin RR was greater during both OL-HDF and HDx as compared to HF (RR 62% vs. 73% vs. 27%, respectively, p = <0.0001), and there was no significant difference between HDx and OL-HDF (p = 0.09). A decrease in serum phosphate levels was observed in the HDx and OL-HDF periods, contrary to an increase in HF (−0.79 mg/dL vs. −1.02 mg/dL vs. + 0.11 mg/dL, respectively, p = <0.0001). There was no difference in RRs of other molecules (BUN, CRP, IL-6, IL-10, TNF-⍺, indoxyl sulfate, and p-Cresol). There was no decrease in serum albumin in any ET.

Conclusion

HDx provides enhanced removal of β2-microglobulin and phosphate as compared to HF, and similar efficacy as with OL-HDF. HDx should be considered an alternative to chronic convective therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemodiafiltrationKidney Failure, ChronicHumansCross-Over StudiesInterleukin-10IndicanInterleukin-6beta 2-MicroglobulinProspective StudiesRenal DialysisSerum AlbuminPhosphorusPhosphatesCresols

Stichwörter der Autor:innen

Chronic hemodialysisExpanded hemodialysisMedium cut-off dialyzersOnline hemodiafiltration

Substanzen

Interleukin-10IndicanInterleukin-6beta 2-MicroglobulinSerum AlbuminPhosphorusPhosphates4-cresolCresols

Autor:innen und Institutionen

  • Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, adrian.caballero24@gmail.com.
  • Postgraduate Division, Faculty of Superior Studies of Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla de Baz, Mexico.

Zitieren

APA

Vega-Vega, O., Caballero-Islas, A. E., Del Toro-Cisneros, N., Hernandez-Ordoñez, S. Ó., Arvizu-Hernández, M., Martínez-Rueda, A., Camacho-Colin, D., Gómez-Correa, L. L., & Correa-Rotter, R. (2023). Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial. Blood Purification, 52(7-8), 712-720. https://doi.org/10.1159/000531355

Vancouver

Vega-Vega O, Caballero-Islas AE, Del Toro-Cisneros N, Hernandez-Ordoñez SÓ, Arvizu-Hernández M, Martínez-Rueda A, et al. Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial. Blood Purification. 2023;52(7-8):712-720. doi:10.1159/000531355

BibTeX
@article{VegaVega2023,
  author = {Vega-Vega, Olynka and Caballero-Islas, Adrián E and Del Toro-Cisneros, Noemí and Hernandez-Ordoñez, Sergio Óscar and Arvizu-Hernández, Mauricio and Martínez-Rueda, Armando and Camacho-Colin, Diana and Gómez-Correa, Leidi Laura and Correa-Rotter, Ricardo},
  title = {Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial},
  journal = {Blood Purification},
  year = {2023},
  volume = {52},
  number = {7-8},
  pages = {712--720},
  doi = {10.1159/000531355}
}
Kostenlos starten →